BIOMAT Database Logo BIOMAT Database Logo

[Availability of nystatin from various dermatologic agents against Candida albicans]. 1976

A E Elkhouly

UI MeSH Term Description Entries
D008566 Membranes Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures. Membrane Tissue,Membrane,Membrane Tissues,Tissue, Membrane,Tissues, Membrane
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009761 Nystatin Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. Fungicidin,Mycostatin,Nilstat,Nystatin A1,Nystatin A2,Nystatin A3,Nystatin G,Stamicin,Stamycin
D009823 Ointment Bases Various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons; vehicles for medicinal substances intended for external application; there are four classes: hydrocarbon base, absorption base, water-removable base and water-soluble base; several are also emollients. Bases, Ointment
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans

Related Publications

A E Elkhouly
Antifungal activity of Punicalagin-nystatin combinations against Candida albicans.
November 2020, Oral diseases,
A E Elkhouly
[Various aspects of Candida albicans infection and its treatment with nystatin].
February 1957, Archivos de pediatria del Uruguay,
A E Elkhouly
Candida albicans plate assay of nystatin.
March 1959, Antibiotics & chemotherapy (Northfield, Ill.),
A E Elkhouly
Investigation of the antifungal effects of curcumin against nystatin-resistant Candida albicans.
January 2023, Dental research journal,
A E Elkhouly
[Effect of nystatin on Candida albicans in the proteolysis culture filtrate of Candida albicans].
November 1971, Zentralblatt fur Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie,
A E Elkhouly
[On the resistance of Candida albicans to nystatin].
January 1969, Journal de pharmacie de Belgique,
A E Elkhouly
Nystatin in the treatment of Candida albicans infections.
April 1957, Southern medical journal,
A E Elkhouly
Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.
September 2013, The Journal of antimicrobial chemotherapy,
A E Elkhouly
CANDIDA ALBICANS CYSTITIS CURED BY NYSTATIN BLADDER INSTILLATIONS.
May 1965, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
A E Elkhouly
Nystatin-resistance of candida albicans isolates from two cases of oral candidiasis.
December 1982, The British journal of oral surgery,
Copied contents to your clipboard!